These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11192447)

  • 1. Prevalence of ocular hemorrhage in patients receiving warfarin therapy.
    Superstein R; Gomolin JE; Hammouda W; Rosenberg A; Overbury O; Arsenault C
    Can J Ophthalmol; 2000 Dec; 35(7):385-9. PubMed ID: 11192447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications.
    Shieh WS; Sridhar J; Hong BK; Maguire JI; Rahimy E; Shahlaee A; Ho AC; Hsu J; Regillo CD; Chiang A
    Semin Ophthalmol; 2017; 32(5):614-619. PubMed ID: 27367495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
    Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
    Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular bleeding related to warfarin anticoagulation in patients with mechanical heart valve and atrial fibrillation.
    Biyik I; Mercan I; Ergene O; Oto O
    J Int Med Res; 2007; 35(1):143-9. PubMed ID: 17408066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A warfarin-induced subconjunctival hemorrhage.
    Bodack MI
    Optometry; 2007 Mar; 78(3):113-8. PubMed ID: 17321459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive subretinal hemorrhage and anticoagulant therapy.
    Brown GC; Tasman WS; Shields JA
    Can J Ophthalmol; 1982 Oct; 17(5):227-30. PubMed ID: 7172112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.
    Ryan A; Saad T; Kirwan C; Keegan DJ; Acheson RW
    Clin Exp Ophthalmol; 2013; 41(4):387-95. PubMed ID: 23094982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular haemorrhage associated with anticoagulant therapy.
    Weir CR; Nolan DJ; Holding D; Hammer H
    Acta Ophthalmol Scand; 2000 Aug; 78(4):492-3. PubMed ID: 10990061
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular hemorrhages due to warfarin fluconazole drug interaction in a patient with presumed Candida endophthalmitis.
    Mootha VV; Schluter ML; Das A
    Arch Ophthalmol; 2002 Jan; 120(1):94-5. PubMed ID: 11786068
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral secondary angle-closure glaucoma as a complication of anticoagulation in a nanophthalmic patient.
    Caronia RM; Sturm RT; Fastenberg DM; Berke SJ; Weintraub J
    Am J Ophthalmol; 1998 Aug; 126(2):307-9. PubMed ID: 9727528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratifying the risks of oral anticoagulation in patients with liver disease.
    Efird LM; Mishkin DS; Berlowitz DR; Ash AS; Hylek EM; Ozonoff A; Reisman JI; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):461-7. PubMed ID: 24823958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravitreal injections in patients receiving warfarin anticoagulation.
    Dayani PN; Siddiqi OK; Holekamp NM
    Am J Ophthalmol; 2007 Sep; 144(3):451-3. PubMed ID: 17765427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.
    White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S
    Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
    Higashi MK; Veenstra DL; Kondo LM; Wittkowsky AK; Srinouanprachanh SL; Farin FM; Rettie AE
    JAMA; 2002 Apr; 287(13):1690-8. PubMed ID: 11926893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive subretinal bleed in a patient with background diabetic retinopathy and on treatment with warfarin.
    Raj A; Sekhri R; Salam A; Priya P
    Eye (Lond); 2003 Jul; 17(5):649-52. PubMed ID: 12855977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.